DDrare: Database of Drug Development for Rare Diseases

212. 三尖弁閉鎖症
［臨床試験数：6，薬物数：8（DrugBank：7），標的遺伝子数：8，標的パスウェイ数：12］

Searched query = "Tricuspid atresia", "TA"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Bosentan; Device: Methacetin Breath Test (MBT); Dexmedetomidine; Liothyronine; Liothyronine I 131; MBT; Sildenafil; Vitamin C

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00573066 (ClinicalTrials.gov)	May 2004	11/12/2007	Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery	The Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics of Dexmedetomidine In Infants Post-Operative From Cardiac Surgery	Hypoplastic Left Heart;Tetralogy of Fallot;Tricuspid Atresia	Drug: Dexmedetomidine	Athena Zuppa	NULL	Completed	1 Month	24 Months	All	56	Phase 1	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00573066
(ClinicalTrials.gov)

May 2004

11/12/2007

Understanding Dexmedetomidine In Infants Post-Operative From Cardiac Surgery

The Pharmacokinetics, Pharmacogenetics, and Pharmacodynamics of Dexmedetomidine In Infants Post-Operative From Cardiac Surgery

Hypoplastic Left Heart;Tetralogy of Fallot;Tricuspid Atresia

Drug: Dexmedetomidine

Athena Zuppa

NULL

Completed

1 Month

24 Months

All

Phase 1

NULL